# Commission Implementing Decision (EU) 2018/945 of 22 June 2018 on the communicable diseases and related special health issues to be covered by epidemiological surveillance as well as relevant case definitions (Text with EEA relevance), Division: Laboratory Criteria

Extent: E+W+S+N.I.

At least one of the following four:
Isolation of Leptospira interrogans or any other pathogenic Leptospira spp. from a clinical specimen
Detection of Leptospira interrogans or any other pathogenic Leptospira spp. nucleic acid in a clinical specimen
Demonstration of Leptospira interrogans or any other pathogenic Leptospira spp. by immunofluorescence in a clinical specimen
Leptospira interrogans or any other pathogenic Leptospira spp. specific antibody response

---
Source: https://www.legislation.gov.uk/eudn/2018/945/annex/II/division/3/division/3.23/division/2 (the official version)
Page: https://openlegislation.uk/eu-decision-2018-945/annex-II/division-3/division-3.23/division-2
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.